Natick-based Boston Scientific Corp. has been given the go-ahead from the U.S. Food and Drug Administration to market its FilterWire EX Embolic Protection System to treat saphenous vein graft (SVG) ...
SAN FRANCISCO (MarketWatch) -- Boston Scientific Corp. on Monday said two studies showed a composite 98.1% procedural success rate by its second-generation FilterWire EZ Embolic Protection System in ...
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII) has initiated a voluntary recall of unused WIRION Embolic Protection Systems (WIRION) due to complaints of filter ...
A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results